{"gene":"SAG","run_date":"2026-06-10T07:46:29","timeline":{"discoveries":[{"year":1987,"finding":"Photoactivated rhodopsin is deactivated by a two-step mechanism: rhodopsin kinase phosphorylates light-activated rhodopsin at multiple sites (partially suppressing transducin activation), and then the 48 kDa S-antigen/arrestin binds specifically to phosphorylated rhodopsin to potentiate inhibition, most likely by competing with transducin for binding to phosphorylated rhodopsin.","method":"In vitro biochemical assays measuring transducin-mediated phosphodiesterase activation in rod outer segments with purified rhodopsin kinase and arrestin","journal":"Journal of receptor research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro reconstitution with purified components, foundational mechanistic study replicated by multiple subsequent labs","pmids":["3040978"],"is_preprint":false},{"year":1992,"finding":"Arrestin (SAG) must dissociate from phosphorylated metarhodopsin II to allow rhodopsin recycling; reduction of the photolyzed chromophore all-trans-retinal to all-trans-retinol is essential for arrestin release, chromophore replacement, and phosphate hydrolysis. If all-trans-retinal persists, it forms pseudo-photoproducts (M380) that bind arrestin tightly and block the phototransduction cascade.","method":"Biochemical reconstitution with native disc membranes, purified arrestin, rhodopsin kinase, and retinoids; spectrophotometric monitoring of metarhodopsin species","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with defined components, multiple orthogonal biochemical readouts in a single rigorous study","pmids":["1386362"],"is_preprint":false},{"year":1999,"finding":"Visual arrestin maintains an inactive conformation through a hydrogen-bonded 'polar core' network involving residues Arg175, Asp30, Asp296, Asp303, and Arg382. Interaction of the phosphorylated receptor C-terminal segment with arrestin disrupts this polar core, triggering a global conformational rearrangement that enables high-affinity binding to activated rhodopsin. Mutations disrupting polar core residues bypass the requirement for receptor phosphorylation, allowing arrestin to bind activated unphosphorylated rhodopsin.","method":"Site-directed mutagenesis combined with in vitro binding assays to phosphorylated light-activated rhodopsin; structure-guided second-site suppressor mutations validated the molecular mechanism; interpreted with the contemporaneous crystal structure of arrestin","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis plus in vitro reconstitution plus crystal structure correlation, multiple orthogonal approaches in one rigorous study","pmids":["10206946"],"is_preprint":false},{"year":2000,"finding":"Arrestin contacts rhodopsin via at least three regions: residues 11–30 and 51–70 (N-domain) and residues 231–260 (C-domain), as identified by peptide competition assays. These arrestin peptides also compete with transducin (Gt) binding to metarhodopsin II, indicating that arrestin and transducin share overlapping binding sites on rhodopsin, consistent with the steric competition model of desensitization.","method":"Spectrophotometric peptide competition assay (extra-MII monitor) using native disc membranes; sets of synthetic arrestin peptides spanning the full sequence tested for inhibition of arrestin- and transducin-dependent MII stabilization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — clean in vitro reconstitution assay with peptide competition, single lab, peptide data provide indirect mapping","pmids":["10969086"],"is_preprint":false},{"year":2004,"finding":"Arrestin release from rhodopsin and all-trans-retinal release from the opsin are thermodynamically linked events with similar activation energies; arrestin binding slows retinal release approximately 2-fold and abolishes its pH dependence. Fluorescence labeling of arrestin mutants I72C and S251C revealed burial of these sites at the rhodopsin-arrestin or phospholipid-arrestin interface upon binding to phosphorylated light-activated rhodopsin. Arrestin also binds a post-Meta II photodecay product (possibly Meta III), suggesting a role in limiting free retinal accumulation.","method":"Site-directed fluorescence labeling of arrestin mutants with monobromobimane; fluorescence, EPR, and biochemical (retinal release kinetics) approaches using purified proteins and disc membranes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (fluorescence, EPR, biochemical kinetics) on purified proteins, rigorous quantitative analysis","pmids":["15591052"],"is_preprint":false},{"year":2012,"finding":"Upon binding to phosphorylated light-activated rhodopsin, the 'finger loop' (residues 67–79) of arrestin-1 moves toward the receptor but does not fully extend. A loop containing residue 139 moves unexpectedly away from the finger loop, facilitating receptor binding. Distal loops at residues 157 and 344 show smaller movements. The relative N- and C-domain orientation remains largely unchanged, contradicting a 'clam-shell' opening model of arrestin activation.","method":"Double electron-electron resonance (DEER) EPR spectroscopy using spin-labeled arrestin-1 mutant pairs; distance measurements in free and rhodopsin-bound states","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative structural method (DEER-EPR) with multiple site pairs, directly measures conformational changes in the receptor-bound state","pmids":["23091036"],"is_preprint":false},{"year":2017,"finding":"The C-edge loops of arrestin-1 function as a membrane anchor during rhodopsin binding. Activation of arrestin by receptor-attached phosphates is required for C-edge engagement with the membrane. The C-edge adopts distinct conformations and orientations in the pre-complex (phosphate-activated but not yet tightly bound) versus the high-affinity receptor-bound complex.","method":"Molecular dynamics simulations combined with site-directed fluorescence spectroscopy experiments on arrestin-1 interacting with rhodopsin in membrane","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — MD simulations validated by site-directed fluorescence spectroscopy, two orthogonal approaches, single lab","pmids":["28220785"],"is_preprint":false},{"year":2020,"finding":"Comprehensive mutagenesis of the finger loop in bovine visual arrestin-1 established that the finger loop is the key element of the activation sensor. The majority of finger loop residues are important for binding to light-activated phosphorylated rhodopsin, and six mutations specifically affect binding to the activated (but not phosphorylated-inactive) rhodopsin form, demonstrating that the finger loop specifically detects the active receptor conformation.","method":"Comprehensive alanine-scanning mutagenesis of finger loop residues; cell-free translation of radiolabeled arrestin mutants; in vitro binding assays to purified phosphorylated light-activated rhodopsin and other functional rhodopsin forms; tested in context of truncated (pre-activated) arrestin-1","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis combined with quantitative in vitro binding to defined rhodopsin forms; comprehensive residue-by-residue analysis","pmids":["33159335"],"is_preprint":false},{"year":2021,"finding":"Inositol phosphates (InsPs) bind to the N-domain basic patch of visual arrestin (Arr1), displacing its C-tail and priming arrestin for interaction with rhodopsin. Crystal structures of bovine Arr1 in ligand-free state (with near-complete C-tail model) and InsP-bound states show that C-tail displacement by InsPs is insufficient to activate arrestin (polar core remains intact), suggesting InsPs prime but do not fully activate Arr1.","method":"X-ray crystallography of bovine arrestin-1 (Arr1) in multiple states; structural comparison of ligand-free and InsP-bound forms; C-tail displacement assessed by electron density","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with functional interpretation, two structural states compared, single lab","pmids":["34678158"],"is_preprint":false}],"current_model":"Visual arrestin (SAG/arrestin-1) is maintained in an inactive state by a polar core network of charged residues; upon interaction with the phosphorylated C-terminus of light-activated rhodopsin, this polar core is disrupted, triggering a conformational rearrangement in which the finger loop engages the activated receptor core as an activation sensor, the C-edge loops anchor to the membrane, and arrestin competitively occludes transducin binding to terminate phototransduction; arrestin release is coupled to all-trans-retinal reduction and chromophore exchange, and inositol phosphates can prime arrestin by displacing its C-tail without fully activating it."},"narrative":{"mechanistic_narrative":"SAG (visual arrestin / arrestin-1) terminates rod phototransduction by binding light-activated, rhodopsin-kinase-phosphorylated rhodopsin and sterically occluding transducin, the second step of a two-step receptor deactivation mechanism [PMID:3040978]. Arrestin and transducin share overlapping contact sites on metarhodopsin II, accounting for this competitive, desensitizing mode of inhibition [PMID:10969086]. In its basal state arrestin is held inactive by a hydrogen-bonded polar core (Arg175, Asp30, Asp296, Asp303, Arg382); engagement of the phosphorylated receptor C-terminus disrupts this core to trigger a global conformational rearrangement that licenses high-affinity binding, and polar-core mutations bypass the phosphorylation requirement entirely [PMID:10206946]. The receptor-bound conformational change centers on the finger loop (residues 67–79), which moves toward the receptor and acts as the activation sensor specifically detecting the active rhodopsin conformation, while the relative N- and C-domain orientation is preserved rather than opening clam-shell-like [PMID:23091036, PMID:33159335]; the C-edge loops engage the membrane as an anchor in a phosphate-activation-dependent manner [PMID:28220785]. Arrestin binding is coupled to chromophore turnover: its release is thermodynamically linked to all-trans-retinal reduction and chromophore exchange, and persistent all-trans-retinal traps arrestin on photoproducts to block recycling [PMID:1386362, PMID:15591052]. Inositol phosphates bind the N-domain basic patch and displace the arrestin C-tail to prime, but not fully activate, the receptor-binding state [PMID:34678158].","teleology":[{"year":1987,"claim":"Established that arrestin acts as the second, phosphorylation-dependent step of rhodopsin deactivation, defining its core role in quenching phototransduction.","evidence":"In vitro reconstitution of transducin-driven PDE activation in rod outer segments with purified rhodopsin kinase and arrestin","pmids":["3040978"],"confidence":"High","gaps":["Did not resolve the structural basis of phospho-rhodopsin recognition","Competition with transducin inferred functionally, not mapped to shared residues"]},{"year":1992,"claim":"Showed that arrestin release is gated by chromophore chemistry, linking desensitization to the rhodopsin recycling cycle rather than to an autonomous off-rate.","evidence":"Biochemical reconstitution with native disc membranes plus retinoids and spectrophotometric monitoring of metarhodopsin species","pmids":["1386362"],"confidence":"High","gaps":["Molecular determinants of arrestin binding to M380 pseudo-photoproducts not defined","Kinetic coupling between retinal reduction and arrestin dissociation not quantified"]},{"year":1999,"claim":"Defined the polar core as the molecular switch that keeps arrestin inactive and that phospho-receptor binding disrupts, explaining the phosphorylation requirement at the residue level.","evidence":"Site-directed and second-site suppressor mutagenesis with in vitro binding to phospho-light-activated rhodopsin, interpreted with the arrestin crystal structure","pmids":["10206946"],"confidence":"High","gaps":["Conformational steps downstream of polar-core disruption not resolved in this study","Did not map the receptor-contacting surfaces directly"]},{"year":2000,"claim":"Mapped arrestin's rhodopsin-contacting regions and showed they overlap transducin's binding sites, providing the structural rationale for steric competition.","evidence":"Spectrophotometric peptide competition (extra-MII) assays with synthetic arrestin peptides on disc membranes","pmids":["10969086"],"confidence":"Medium","gaps":["Peptide competition gives indirect mapping, not validated in the intact protein","Single-lab data without orthogonal structural confirmation"]},{"year":2004,"claim":"Demonstrated thermodynamic coupling between arrestin release and retinal release and identified interface residues buried on binding, integrating desensitization with photoproduct decay.","evidence":"Site-directed bimane fluorescence labeling of arrestin mutants with EPR and retinal-release kinetics on purified proteins and disc membranes","pmids":["15591052"],"confidence":"High","gaps":["Whether buried sites contact rhodopsin or phospholipid not fully distinguished","Identity of the post-Meta II decay product only tentatively assigned"]},{"year":2012,"claim":"Resolved the receptor-bound conformational change, showing finger-loop movement without clam-shell domain reorientation and overturning a prevailing activation model.","evidence":"DEER-EPR distance measurements on spin-labeled arrestin-1 mutant pairs in free and rhodopsin-bound states","pmids":["23091036"],"confidence":"High","gaps":["Functional consequence of the loop-139 displacement not tested","Limited to distance pairs sampled"]},{"year":2017,"claim":"Identified the C-edge loops as a phosphate-activation-dependent membrane anchor, adding a lipid-interface component to the binding mechanism.","evidence":"Molecular dynamics simulations validated by site-directed fluorescence spectroscopy on arrestin-1 with rhodopsin in membrane","pmids":["28220785"],"confidence":"High","gaps":["Membrane-anchor contribution to overall binding energetics not quantified","Single-lab combination of simulation and spectroscopy"]},{"year":2020,"claim":"Pinpointed the finger loop as the activation sensor that specifically reads the active receptor conformation, separating activation detection from phosphate sensing.","evidence":"Comprehensive alanine-scanning of finger-loop residues with cell-free translated mutants and in vitro binding to defined rhodopsin forms","pmids":["33159335"],"confidence":"High","gaps":["Structural arrangement of the engaged finger loop in the complex not directly visualized","Cooperativity with C-edge and phosphate sensing not dissected"]},{"year":2021,"claim":"Showed that inositol phosphates prime arrestin by displacing its C-tail at the N-domain basic patch without disrupting the polar core, distinguishing priming from full activation.","evidence":"X-ray crystallography of bovine arrestin-1 in ligand-free and InsP-bound states","pmids":["34678158"],"confidence":"High","gaps":["Physiological role of InsP priming in vivo not established","How priming accelerates subsequent rhodopsin engagement not kinetically defined"]},{"year":null,"claim":"How the priming, phosphate-sensing, finger-loop activation, and membrane-anchoring steps are temporally ordered into a single high-affinity complex in the native rod remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No integrated kinetic model coupling InsP priming to receptor engagement","In vivo relevance of individual binding elements not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3]}],"complexes":[],"partners":["RHO"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P10523","full_name":"S-arrestin","aliases":["48 kDa protein","Retinal S-antigen","S-AG","Rod photoreceptor arrestin"],"length_aa":405,"mass_kda":45.1,"function":"Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO (By similarity). May play a role in preventing light-dependent degeneration of retinal photoreceptor cells (PubMed:9565049)","subcellular_location":"Cell projection, cilium, photoreceptor outer segment; Membrane","url":"https://www.uniprot.org/uniprotkb/P10523/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SAG","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SAG","total_profiled":1310},"omim":[{"mim_id":"620880","title":"AUTOINFLAMMATION WITH ARTHRITIS AND VASCULITIS; AIARV","url":"https://www.omim.org/entry/620880"},{"mim_id":"620228","title":"RETINITIS PIGMENTOSA 96; RP96","url":"https://www.omim.org/entry/620228"},{"mim_id":"619788","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 4; ARRDC4","url":"https://www.omim.org/entry/619788"},{"mim_id":"617728","title":"CENTROSOMAL PROTEIN, 295-KD; CEP295","url":"https://www.omim.org/entry/617728"},{"mim_id":"617700","title":"UBIQUITIN-CONJUGATING ENZYME E2 F; UBE2F","url":"https://www.omim.org/entry/617700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":1359.9}],"url":"https://www.proteinatlas.org/search/SAG"},"hgnc":{"alias_symbol":["ARRESTIN","RP47"],"prev_symbol":[]},"alphafold":{"accession":"P10523","domains":[{"cath_id":"2.60.40.840","chopping":"15-184_365-382","consensus_level":"high","plddt":85.7331,"start":15,"end":382},{"cath_id":"2.60.40.640","chopping":"194-361","consensus_level":"high","plddt":91.9445,"start":194,"end":361}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10523","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10523-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10523-F1-predicted_aligned_error_v6.png","plddt_mean":85.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SAG","jax_strain_url":"https://www.jax.org/strain/search?query=SAG"},"sequence":{"accession":"P10523","fasta_url":"https://rest.uniprot.org/uniprotkb/P10523.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10523/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10523"}},"corpus_meta":[{"pmid":"2163110","id":"PMC_2163110","title":"beta-Arrestin: a protein that regulates beta-adrenergic receptor function.","date":"1990","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2163110","citation_count":1027,"is_preprint":false},{"pmid":"21680031","id":"PMC_21680031","title":"β-Arrestin-mediated receptor trafficking and signal transduction.","date":"2011","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21680031","citation_count":590,"is_preprint":false},{"pmid":"17644195","id":"PMC_17644195","title":"Beta-arrestin-biased ligands at seven-transmembrane receptors.","date":"2007","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17644195","citation_count":504,"is_preprint":false},{"pmid":"20427692","id":"PMC_20427692","title":"Beyond desensitization: physiological relevance of arrestin-dependent signaling.","date":"2010","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20427692","citation_count":301,"is_preprint":false},{"pmid":"15102497","id":"PMC_15102497","title":"The molecular acrobatics of arrestin activation.","date":"2004","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15102497","citation_count":277,"is_preprint":false},{"pmid":"18787115","id":"PMC_18787115","title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18787115","citation_count":235,"is_preprint":false},{"pmid":"18086673","id":"PMC_18086673","title":"beta-arrestin-biased agonism at the beta2-adrenergic receptor.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086673","citation_count":219,"is_preprint":false},{"pmid":"17215450","id":"PMC_17215450","title":"Beta-arrestin signaling and regulation of transcription.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17215450","citation_count":215,"is_preprint":false},{"pmid":"18664266","id":"PMC_18664266","title":"On the origins of arrestin and rhodopsin.","date":"2008","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/18664266","citation_count":194,"is_preprint":false},{"pmid":"29720660","id":"PMC_29720660","title":"Catalytic activation of β-arrestin by GPCRs.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29720660","citation_count":171,"is_preprint":false},{"pmid":"29720655","id":"PMC_29720655","title":"Molecular mechanism of GPCR-mediated arrestin activation.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29720655","citation_count":169,"is_preprint":false},{"pmid":"16267056","id":"PMC_16267056","title":"Seven-transmembrane receptor signaling through beta-arrestin.","date":"2005","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/16267056","citation_count":154,"is_preprint":false},{"pmid":"10206946","id":"PMC_10206946","title":"How does arrestin respond to the phosphorylated state of rhodopsin?","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10206946","citation_count":153,"is_preprint":false},{"pmid":"19001375","id":"PMC_19001375","title":"How does arrestin assemble MAPKs into a signaling complex?","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19001375","citation_count":147,"is_preprint":false},{"pmid":"15001578","id":"PMC_15001578","title":"Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15001578","citation_count":143,"is_preprint":false},{"pmid":"8340388","id":"PMC_8340388","title":"Polypeptide variants of beta-arrestin and arrestin3.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8340388","citation_count":137,"is_preprint":false},{"pmid":"33296703","id":"PMC_33296703","title":"How GPCR Phosphorylation Patterns Orchestrate Arrestin-Mediated Signaling.","date":"2020","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33296703","citation_count":130,"is_preprint":false},{"pmid":"1386362","id":"PMC_1386362","title":"The role of arrestin and retinoids in the regeneration pathway of rhodopsin.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1386362","citation_count":130,"is_preprint":false},{"pmid":"26471844","id":"PMC_26471844","title":"Emerging Functional Divergence of β-Arrestin Isoforms in GPCR Function.","date":"2015","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/26471844","citation_count":117,"is_preprint":false},{"pmid":"14530255","id":"PMC_14530255","title":"Mapping the arrestin-receptor interface. Structural elements responsible for receptor specificity of arrestin proteins.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14530255","citation_count":116,"is_preprint":false},{"pmid":"15780588","id":"PMC_15780588","title":"Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.","date":"2005","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15780588","citation_count":109,"is_preprint":false},{"pmid":"29127291","id":"PMC_29127291","title":"Structural basis of arrestin-3 activation and signaling.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29127291","citation_count":107,"is_preprint":false},{"pmid":"28181498","id":"PMC_28181498","title":"Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28181498","citation_count":103,"is_preprint":false},{"pmid":"3040978","id":"PMC_3040978","title":"Deactivation of photoactivated rhodopsin by rhodopsin-kinase and arrestin.","date":"1987","source":"Journal of receptor research","url":"https://pubmed.ncbi.nlm.nih.gov/3040978","citation_count":98,"is_preprint":false},{"pmid":"11160859","id":"PMC_11160859","title":"Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor.","date":"2001","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11160859","citation_count":96,"is_preprint":false},{"pmid":"20189994","id":"PMC_20189994","title":"Morphine-like opiates selectively antagonize receptor-arrestin interactions.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20189994","citation_count":90,"is_preprint":false},{"pmid":"29872229","id":"PMC_29872229","title":"Molecular mechanism of modulating arrestin conformation by GPCR phosphorylation.","date":"2018","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29872229","citation_count":87,"is_preprint":false},{"pmid":"28220785","id":"PMC_28220785","title":"C-edge loops of arrestin function as a membrane anchor.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28220785","citation_count":86,"is_preprint":false},{"pmid":"23091036","id":"PMC_23091036","title":"Conformation of receptor-bound visual arrestin.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23091036","citation_count":84,"is_preprint":false},{"pmid":"24430184","id":"PMC_24430184","title":"Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24430184","citation_count":81,"is_preprint":false},{"pmid":"23136067","id":"PMC_23136067","title":"Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.","date":"2012","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/23136067","citation_count":80,"is_preprint":false},{"pmid":"18276584","id":"PMC_18276584","title":"Beta-arrestin-mediated signaling regulates protein synthesis.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18276584","citation_count":80,"is_preprint":false},{"pmid":"19100766","id":"PMC_19100766","title":"Physiological and pharmacological implications of beta-arrestin regulation.","date":"2008","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/19100766","citation_count":80,"is_preprint":false},{"pmid":"14769794","id":"PMC_14769794","title":"Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14769794","citation_count":78,"is_preprint":false},{"pmid":"29636212","id":"PMC_29636212","title":"Structural Basis of Arrestin-Dependent Signal Transduction.","date":"2018","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29636212","citation_count":72,"is_preprint":false},{"pmid":"37146613","id":"PMC_37146613","title":"Plasma membrane preassociation drives β-arrestin coupling to receptors and activation.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37146613","citation_count":70,"is_preprint":false},{"pmid":"10969086","id":"PMC_10969086","title":"Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10969086","citation_count":68,"is_preprint":false},{"pmid":"15591052","id":"PMC_15591052","title":"Dynamics of arrestin-rhodopsin interactions: arrestin and retinal release are directly linked events.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15591052","citation_count":67,"is_preprint":false},{"pmid":"25831532","id":"PMC_25831532","title":"β-Arrestin-biased signaling mediates memory reconsolidation.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25831532","citation_count":63,"is_preprint":false},{"pmid":"33557162","id":"PMC_33557162","title":"Receptor-Arrestin Interactions: The GPCR Perspective.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33557162","citation_count":61,"is_preprint":false},{"pmid":"28558341","id":"PMC_28558341","title":"Understanding the GPCR biased signaling through G protein and arrestin complex structures.","date":"2017","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/28558341","citation_count":61,"is_preprint":false},{"pmid":"25261469","id":"PMC_25261469","title":"G Protein and β-arrestin signaling bias at the ghrelin receptor.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25261469","citation_count":61,"is_preprint":false},{"pmid":"24292823","id":"PMC_24292823","title":"Arrestin interactions with G protein-coupled receptors.","date":"2014","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24292823","citation_count":60,"is_preprint":false},{"pmid":"37558880","id":"PMC_37558880","title":"Tail engagement of arrestin at the glucagon receptor.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37558880","citation_count":56,"is_preprint":false},{"pmid":"28600951","id":"PMC_28600951","title":"Structural mechanism of arrestin activation.","date":"2017","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/28600951","citation_count":56,"is_preprint":false},{"pmid":"30120413","id":"PMC_30120413","title":"Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation.","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30120413","citation_count":55,"is_preprint":false},{"pmid":"23764050","id":"PMC_23764050","title":"Structural determinants of arrestin functions.","date":"2013","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/23764050","citation_count":54,"is_preprint":false},{"pmid":"10443936","id":"PMC_10443936","title":"Expression, purification, and biochemical characterization of SAG, a ring finger redox-sensitive protein.","date":"1999","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10443936","citation_count":52,"is_preprint":false},{"pmid":"37844230","id":"PMC_37844230","title":"Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37844230","citation_count":51,"is_preprint":false},{"pmid":"19597700","id":"PMC_19597700","title":"Diversity in arrestin function.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19597700","citation_count":51,"is_preprint":false},{"pmid":"18838825","id":"PMC_18838825","title":"Beta-arrestin-mediated signaling in the heart.","date":"2008","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/18838825","citation_count":47,"is_preprint":false},{"pmid":"31127272","id":"PMC_31127272","title":"Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk.","date":"2019","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31127272","citation_count":46,"is_preprint":false},{"pmid":"24723693","id":"PMC_24723693","title":"β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24723693","citation_count":45,"is_preprint":false},{"pmid":"32632293","id":"PMC_32632293","title":"Allosteric interactions in the parathyroid hormone GPCR-arrestin complex formation.","date":"2020","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32632293","citation_count":45,"is_preprint":false},{"pmid":"8475065","id":"PMC_8475065","title":"Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8475065","citation_count":45,"is_preprint":false},{"pmid":"32888497","id":"PMC_32888497","title":"SnapShot: β-Arrestin Functions.","date":"2020","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/32888497","citation_count":44,"is_preprint":false},{"pmid":"27911784","id":"PMC_27911784","title":"β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27911784","citation_count":44,"is_preprint":false},{"pmid":"25446289","id":"PMC_25446289","title":"Overview of different mechanisms of arrestin-mediated signaling.","date":"2014","source":"Current protocols in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446289","citation_count":43,"is_preprint":false},{"pmid":"23764049","id":"PMC_23764049","title":"True arrestins and arrestin-fold proteins: a structure-based appraisal.","date":"2013","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/23764049","citation_count":42,"is_preprint":false},{"pmid":"30894814","id":"PMC_30894814","title":"Therapeutic Potential of Targeting ß-Arrestin.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30894814","citation_count":40,"is_preprint":false},{"pmid":"24907413","id":"PMC_24907413","title":"Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.","date":"2014","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24907413","citation_count":40,"is_preprint":false},{"pmid":"32929862","id":"PMC_32929862","title":"Exploring GPCR-arrestin interfaces with genetically encoded crosslinkers.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32929862","citation_count":39,"is_preprint":false},{"pmid":"16325568","id":"PMC_16325568","title":"Beta-arrestin goes nuclear.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16325568","citation_count":38,"is_preprint":false},{"pmid":"23891976","id":"PMC_23891976","title":"Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.","date":"2013","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23891976","citation_count":38,"is_preprint":false},{"pmid":"30595812","id":"PMC_30595812","title":"Arrestin-mediated signaling: Is there a controversy?","date":"2018","source":"World journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30595812","citation_count":37,"is_preprint":false},{"pmid":"30591558","id":"PMC_30591558","title":"Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30591558","citation_count":37,"is_preprint":false},{"pmid":"28174117","id":"PMC_28174117","title":"β-arrestin signalling and bias in hormone-responsive GPCRs.","date":"2017","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28174117","citation_count":36,"is_preprint":false},{"pmid":"20100567","id":"PMC_20100567","title":"Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult.","date":"2010","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20100567","citation_count":36,"is_preprint":false},{"pmid":"30703488","id":"PMC_30703488","title":"The structural basis of the arrestin binding to GPCRs.","date":"2019","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30703488","citation_count":35,"is_preprint":false},{"pmid":"26921391","id":"PMC_26921391","title":"β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.","date":"2016","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/26921391","citation_count":35,"is_preprint":false},{"pmid":"31849219","id":"PMC_31849219","title":"β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs.","date":"2019","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/31849219","citation_count":33,"is_preprint":false},{"pmid":"22610101","id":"PMC_22610101","title":"Arrestin scaffolds NHERF1 to the P2Y12 receptor to regulate receptor internalization.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22610101","citation_count":31,"is_preprint":false},{"pmid":"38906769","id":"PMC_38906769","title":"GPCR-dependent and -independent arrestin signaling.","date":"2024","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38906769","citation_count":30,"is_preprint":false},{"pmid":"27543965","id":"PMC_27543965","title":"SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27543965","citation_count":29,"is_preprint":false},{"pmid":"34465145","id":"PMC_34465145","title":"The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer.","date":"2022","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34465145","citation_count":28,"is_preprint":false},{"pmid":"25446290","id":"PMC_25446290","title":"Arrestin expression in E. coli and purification.","date":"2014","source":"Current protocols in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446290","citation_count":26,"is_preprint":false},{"pmid":"35910860","id":"PMC_35910860","title":"β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells.","date":"2022","source":"Frontiers in allergy","url":"https://pubmed.ncbi.nlm.nih.gov/35910860","citation_count":26,"is_preprint":false},{"pmid":"34740971","id":"PMC_34740971","title":"Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34740971","citation_count":26,"is_preprint":false},{"pmid":"31659746","id":"PMC_31659746","title":"Arrestin-independent constitutive endocytosis of GPR125/ADGRA3.","date":"2019","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31659746","citation_count":25,"is_preprint":false},{"pmid":"31399503","id":"PMC_31399503","title":"Calcium-Sensing Receptor Internalization Is β-Arrestin-Dependent and Modulated by Allosteric Ligands.","date":"2019","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31399503","citation_count":25,"is_preprint":false},{"pmid":"33159335","id":"PMC_33159335","title":"The finger loop as an activation sensor in arrestin.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33159335","citation_count":25,"is_preprint":false},{"pmid":"23360390","id":"PMC_23360390","title":"Phosphorylation regulates TRPV1 association with β-arrestin-2.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23360390","citation_count":25,"is_preprint":false},{"pmid":"25401926","id":"PMC_25401926","title":"β-Arrestin-dependent deactivation of mouse melanopsin.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25401926","citation_count":24,"is_preprint":false},{"pmid":"25425623","id":"PMC_25425623","title":"Engineered hyperphosphorylation of the β2-adrenoceptor prolongs arrestin-3 binding and induces arrestin internalization.","date":"2014","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25425623","citation_count":23,"is_preprint":false},{"pmid":"26825061","id":"PMC_26825061","title":"Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.","date":"2016","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/26825061","citation_count":22,"is_preprint":false},{"pmid":"35427647","id":"PMC_35427647","title":"Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35427647","citation_count":22,"is_preprint":false},{"pmid":"25484000","id":"PMC_25484000","title":"Molecular mechanism of phosphorylation-dependent arrestin activation.","date":"2014","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/25484000","citation_count":21,"is_preprint":false},{"pmid":"34678158","id":"PMC_34678158","title":"Structural evidence for visual arrestin priming via complexation of phosphoinositols.","date":"2021","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/34678158","citation_count":21,"is_preprint":false},{"pmid":"26582201","id":"PMC_26582201","title":"β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26582201","citation_count":21,"is_preprint":false},{"pmid":"28419873","id":"PMC_28419873","title":"Arrestin-2 and arrestin-3 differentially modulate locomotor responses and sensitization to amphetamine.","date":"2017","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28419873","citation_count":20,"is_preprint":false},{"pmid":"22447307","id":"PMC_22447307","title":"β-arrestin-mediated signaling improves the efficacy of therapeutics.","date":"2012","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22447307","citation_count":20,"is_preprint":false},{"pmid":"32803684","id":"PMC_32803684","title":"Many faces of the GPCR-arrestin interaction.","date":"2020","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/32803684","citation_count":19,"is_preprint":false},{"pmid":"31080119","id":"PMC_31080119","title":"Structural Mechanism of the Arrestin-3/JNK3 Interaction.","date":"2019","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/31080119","citation_count":19,"is_preprint":false},{"pmid":"29330504","id":"PMC_29330504","title":"Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29330504","citation_count":19,"is_preprint":false},{"pmid":"23764065","id":"PMC_23764065","title":"Arrestin pathways as drug targets.","date":"2013","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/23764065","citation_count":18,"is_preprint":false},{"pmid":"23319470","id":"PMC_23319470","title":"β-Arrestin-kinase scaffolds: turn them on or turn them off?","date":"2013","source":"Wiley interdisciplinary reviews. Systems biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23319470","citation_count":17,"is_preprint":false},{"pmid":"29411438","id":"PMC_29411438","title":"A rapid fluorogenic GPCR-β-arrestin interaction assay.","date":"2018","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/29411438","citation_count":17,"is_preprint":false},{"pmid":"33564089","id":"PMC_33564089","title":"CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33564089","citation_count":17,"is_preprint":false},{"pmid":"10443588","id":"PMC_10443588","title":"Phosducin, beta-arrestin and opioid receptor migration.","date":"1999","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10443588","citation_count":17,"is_preprint":false},{"pmid":"1376775","id":"PMC_1376775","title":"SAG: a Schwann cell membrane glycoprotein.","date":"1992","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/1376775","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43838,"output_tokens":3538,"usd":0.092292,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9934,"output_tokens":2971,"usd":0.061972,"stage2_stop_reason":"end_turn"},"total_usd":0.154264,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking at the corpus, I need to identify which papers are about the canonical SAG gene (also known as RBX2, ROC2, RNF7 - a RING finger E3 ubiquitin ligase) versus papers about arrestin/beta-arrestin proteins (which appear under ARRESTIN and RP47 aliases listed for SAG).\n\nWait - the HGNC aliases listed are ARRESTIN and RP47. Let me reconsider: the gene symbol SAG with aliases ARRESTIN and RP47 refers to **S-Antigen (retinal arrestin / visual arrestin)**, not RBX2. SAG = S-Antigen Gene = retinal/visual arrestin (arrestin-1). This is distinct from beta-arrestins (ARRB1, ARRB2) and from RBX2/ROC2.\n\nSo I need to extract findings specifically about visual arrestin (SAG/arrestin-1/S-antigen/48K protein), not beta-arrestins, not RBX2. Papers about RBX2/ROC2 (PMIDs 24430184, 23136067, 10443936, 27543965, 20100567) are about a different gene that shares the SAG symbol - these are collision papers.\n\nLet me carefully identify papers specifically about visual arrestin (SAG/arrestin-1):\n\n- PMID 3040978: Deactivation of rhodopsin by rhodopsin-kinase and arrestin (48K/S-antigen) ✓\n- PMID 1386362: Role of arrestin and retinoids in rhodopsin regeneration ✓\n- PMID 10206946: How arrestin responds to phosphorylated rhodopsin - structure/function ✓\n- PMID 15591052: Dynamics of arrestin-rhodopsin interactions - arrestin and retinal release ✓\n- PMID 10969086: Interactions of metarhodopsin II, arrestin peptides ✓\n- PMID 23091036: Conformation of receptor-bound visual arrestin ✓\n- PMID 28220785: C-edge loops as membrane anchor ✓\n- PMID 33159335: Finger loop as activation sensor in arrestin ✓\n- PMID 34678158: Structural evidence for visual arrestin priming via phosphoinositols ✓\n- PMID 10443936: SAG biochemical characterization (RBX2) - this is RBX2, EXCLUDE\n- PMID 20100567: Tat-SAG fusion (RBX2) - EXCLUDE\n- PMID 24430184: SAG/RBX2 E3 ligase - EXCLUDE\n- PMID 23136067: SAG/RBX2 functional characterization - EXCLUDE\n- PMID 27543965: SAG/Rbx2 neddylation - EXCLUDE\n- PMID 1376775: SAG Schwann cell glycoprotein - different protein, EXCLUDE\n\nPapers about beta-arrestins (ARRB1/2) are NOT SAG - SAG is specifically visual arrestin (arrestin-1). However, some papers discuss arrestin-1 mechanisms alongside others. Let me be careful to only extract findings explicitly about visual arrestin/SAG/arrestin-1.\n\nPapers like PMID 10206946 (Vishnivetskiy et al.) specifically study visual arrestin structure-function. PMID 23091036 studies arrestin-1. PMID 28220785 studies arrestin-1 with rhodopsin. PMID 33159335 studies bovine visual arrestin-1. PMID 34678158 studies visual arrestin (Arr1). PMID 15591052 studies visual arrestin. PMID 10969086 studies arrestin with rhodopsin.\n\nFor papers about all four arrestins including arrestin-1 (e.g., PMID 19001375 - Song et al.), I'll include findings specific to arrestin-1 where distinguishable.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"Photoactivated rhodopsin is deactivated by a two-step mechanism: rhodopsin kinase phosphorylates light-activated rhodopsin at multiple sites (partially suppressing transducin activation), and then the 48 kDa S-antigen/arrestin binds specifically to phosphorylated rhodopsin to potentiate inhibition, most likely by competing with transducin for binding to phosphorylated rhodopsin.\",\n      \"method\": \"In vitro biochemical assays measuring transducin-mediated phosphodiesterase activation in rod outer segments with purified rhodopsin kinase and arrestin\",\n      \"journal\": \"Journal of receptor research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro reconstitution with purified components, foundational mechanistic study replicated by multiple subsequent labs\",\n      \"pmids\": [\"3040978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Arrestin (SAG) must dissociate from phosphorylated metarhodopsin II to allow rhodopsin recycling; reduction of the photolyzed chromophore all-trans-retinal to all-trans-retinol is essential for arrestin release, chromophore replacement, and phosphate hydrolysis. If all-trans-retinal persists, it forms pseudo-photoproducts (M380) that bind arrestin tightly and block the phototransduction cascade.\",\n      \"method\": \"Biochemical reconstitution with native disc membranes, purified arrestin, rhodopsin kinase, and retinoids; spectrophotometric monitoring of metarhodopsin species\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with defined components, multiple orthogonal biochemical readouts in a single rigorous study\",\n      \"pmids\": [\"1386362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Visual arrestin maintains an inactive conformation through a hydrogen-bonded 'polar core' network involving residues Arg175, Asp30, Asp296, Asp303, and Arg382. Interaction of the phosphorylated receptor C-terminal segment with arrestin disrupts this polar core, triggering a global conformational rearrangement that enables high-affinity binding to activated rhodopsin. Mutations disrupting polar core residues bypass the requirement for receptor phosphorylation, allowing arrestin to bind activated unphosphorylated rhodopsin.\",\n      \"method\": \"Site-directed mutagenesis combined with in vitro binding assays to phosphorylated light-activated rhodopsin; structure-guided second-site suppressor mutations validated the molecular mechanism; interpreted with the contemporaneous crystal structure of arrestin\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis plus in vitro reconstitution plus crystal structure correlation, multiple orthogonal approaches in one rigorous study\",\n      \"pmids\": [\"10206946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Arrestin contacts rhodopsin via at least three regions: residues 11–30 and 51–70 (N-domain) and residues 231–260 (C-domain), as identified by peptide competition assays. These arrestin peptides also compete with transducin (Gt) binding to metarhodopsin II, indicating that arrestin and transducin share overlapping binding sites on rhodopsin, consistent with the steric competition model of desensitization.\",\n      \"method\": \"Spectrophotometric peptide competition assay (extra-MII monitor) using native disc membranes; sets of synthetic arrestin peptides spanning the full sequence tested for inhibition of arrestin- and transducin-dependent MII stabilization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — clean in vitro reconstitution assay with peptide competition, single lab, peptide data provide indirect mapping\",\n      \"pmids\": [\"10969086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Arrestin release from rhodopsin and all-trans-retinal release from the opsin are thermodynamically linked events with similar activation energies; arrestin binding slows retinal release approximately 2-fold and abolishes its pH dependence. Fluorescence labeling of arrestin mutants I72C and S251C revealed burial of these sites at the rhodopsin-arrestin or phospholipid-arrestin interface upon binding to phosphorylated light-activated rhodopsin. Arrestin also binds a post-Meta II photodecay product (possibly Meta III), suggesting a role in limiting free retinal accumulation.\",\n      \"method\": \"Site-directed fluorescence labeling of arrestin mutants with monobromobimane; fluorescence, EPR, and biochemical (retinal release kinetics) approaches using purified proteins and disc membranes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (fluorescence, EPR, biochemical kinetics) on purified proteins, rigorous quantitative analysis\",\n      \"pmids\": [\"15591052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Upon binding to phosphorylated light-activated rhodopsin, the 'finger loop' (residues 67–79) of arrestin-1 moves toward the receptor but does not fully extend. A loop containing residue 139 moves unexpectedly away from the finger loop, facilitating receptor binding. Distal loops at residues 157 and 344 show smaller movements. The relative N- and C-domain orientation remains largely unchanged, contradicting a 'clam-shell' opening model of arrestin activation.\",\n      \"method\": \"Double electron-electron resonance (DEER) EPR spectroscopy using spin-labeled arrestin-1 mutant pairs; distance measurements in free and rhodopsin-bound states\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative structural method (DEER-EPR) with multiple site pairs, directly measures conformational changes in the receptor-bound state\",\n      \"pmids\": [\"23091036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The C-edge loops of arrestin-1 function as a membrane anchor during rhodopsin binding. Activation of arrestin by receptor-attached phosphates is required for C-edge engagement with the membrane. The C-edge adopts distinct conformations and orientations in the pre-complex (phosphate-activated but not yet tightly bound) versus the high-affinity receptor-bound complex.\",\n      \"method\": \"Molecular dynamics simulations combined with site-directed fluorescence spectroscopy experiments on arrestin-1 interacting with rhodopsin in membrane\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — MD simulations validated by site-directed fluorescence spectroscopy, two orthogonal approaches, single lab\",\n      \"pmids\": [\"28220785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Comprehensive mutagenesis of the finger loop in bovine visual arrestin-1 established that the finger loop is the key element of the activation sensor. The majority of finger loop residues are important for binding to light-activated phosphorylated rhodopsin, and six mutations specifically affect binding to the activated (but not phosphorylated-inactive) rhodopsin form, demonstrating that the finger loop specifically detects the active receptor conformation.\",\n      \"method\": \"Comprehensive alanine-scanning mutagenesis of finger loop residues; cell-free translation of radiolabeled arrestin mutants; in vitro binding assays to purified phosphorylated light-activated rhodopsin and other functional rhodopsin forms; tested in context of truncated (pre-activated) arrestin-1\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis combined with quantitative in vitro binding to defined rhodopsin forms; comprehensive residue-by-residue analysis\",\n      \"pmids\": [\"33159335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Inositol phosphates (InsPs) bind to the N-domain basic patch of visual arrestin (Arr1), displacing its C-tail and priming arrestin for interaction with rhodopsin. Crystal structures of bovine Arr1 in ligand-free state (with near-complete C-tail model) and InsP-bound states show that C-tail displacement by InsPs is insufficient to activate arrestin (polar core remains intact), suggesting InsPs prime but do not fully activate Arr1.\",\n      \"method\": \"X-ray crystallography of bovine arrestin-1 (Arr1) in multiple states; structural comparison of ligand-free and InsP-bound forms; C-tail displacement assessed by electron density\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with functional interpretation, two structural states compared, single lab\",\n      \"pmids\": [\"34678158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Visual arrestin (SAG/arrestin-1) is maintained in an inactive state by a polar core network of charged residues; upon interaction with the phosphorylated C-terminus of light-activated rhodopsin, this polar core is disrupted, triggering a conformational rearrangement in which the finger loop engages the activated receptor core as an activation sensor, the C-edge loops anchor to the membrane, and arrestin competitively occludes transducin binding to terminate phototransduction; arrestin release is coupled to all-trans-retinal reduction and chromophore exchange, and inositol phosphates can prime arrestin by displacing its C-tail without fully activating it.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SAG (visual arrestin / arrestin-1) terminates rod phototransduction by binding light-activated, rhodopsin-kinase-phosphorylated rhodopsin and sterically occluding transducin, the second step of a two-step receptor deactivation mechanism [#0]. Arrestin and transducin share overlapping contact sites on metarhodopsin II, accounting for this competitive, desensitizing mode of inhibition [#3]. In its basal state arrestin is held inactive by a hydrogen-bonded polar core (Arg175, Asp30, Asp296, Asp303, Arg382); engagement of the phosphorylated receptor C-terminus disrupts this core to trigger a global conformational rearrangement that licenses high-affinity binding, and polar-core mutations bypass the phosphorylation requirement entirely [#2]. The receptor-bound conformational change centers on the finger loop (residues 67–79), which moves toward the receptor and acts as the activation sensor specifically detecting the active rhodopsin conformation, while the relative N- and C-domain orientation is preserved rather than opening clam-shell-like [#5, #7]; the C-edge loops engage the membrane as an anchor in a phosphate-activation-dependent manner [#6]. Arrestin binding is coupled to chromophore turnover: its release is thermodynamically linked to all-trans-retinal reduction and chromophore exchange, and persistent all-trans-retinal traps arrestin on photoproducts to block recycling [#1, #4]. Inositol phosphates bind the N-domain basic patch and displace the arrestin C-tail to prime, but not fully activate, the receptor-binding state [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Established that arrestin acts as the second, phosphorylation-dependent step of rhodopsin deactivation, defining its core role in quenching phototransduction.\",\n      \"evidence\": \"In vitro reconstitution of transducin-driven PDE activation in rod outer segments with purified rhodopsin kinase and arrestin\",\n      \"pmids\": [\"3040978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of phospho-rhodopsin recognition\", \"Competition with transducin inferred functionally, not mapped to shared residues\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Showed that arrestin release is gated by chromophore chemistry, linking desensitization to the rhodopsin recycling cycle rather than to an autonomous off-rate.\",\n      \"evidence\": \"Biochemical reconstitution with native disc membranes plus retinoids and spectrophotometric monitoring of metarhodopsin species\",\n      \"pmids\": [\"1386362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular determinants of arrestin binding to M380 pseudo-photoproducts not defined\", \"Kinetic coupling between retinal reduction and arrestin dissociation not quantified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the polar core as the molecular switch that keeps arrestin inactive and that phospho-receptor binding disrupts, explaining the phosphorylation requirement at the residue level.\",\n      \"evidence\": \"Site-directed and second-site suppressor mutagenesis with in vitro binding to phospho-light-activated rhodopsin, interpreted with the arrestin crystal structure\",\n      \"pmids\": [\"10206946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational steps downstream of polar-core disruption not resolved in this study\", \"Did not map the receptor-contacting surfaces directly\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapped arrestin's rhodopsin-contacting regions and showed they overlap transducin's binding sites, providing the structural rationale for steric competition.\",\n      \"evidence\": \"Spectrophotometric peptide competition (extra-MII) assays with synthetic arrestin peptides on disc membranes\",\n      \"pmids\": [\"10969086\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peptide competition gives indirect mapping, not validated in the intact protein\", \"Single-lab data without orthogonal structural confirmation\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated thermodynamic coupling between arrestin release and retinal release and identified interface residues buried on binding, integrating desensitization with photoproduct decay.\",\n      \"evidence\": \"Site-directed bimane fluorescence labeling of arrestin mutants with EPR and retinal-release kinetics on purified proteins and disc membranes\",\n      \"pmids\": [\"15591052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether buried sites contact rhodopsin or phospholipid not fully distinguished\", \"Identity of the post-Meta II decay product only tentatively assigned\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved the receptor-bound conformational change, showing finger-loop movement without clam-shell domain reorientation and overturning a prevailing activation model.\",\n      \"evidence\": \"DEER-EPR distance measurements on spin-labeled arrestin-1 mutant pairs in free and rhodopsin-bound states\",\n      \"pmids\": [\"23091036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the loop-139 displacement not tested\", \"Limited to distance pairs sampled\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified the C-edge loops as a phosphate-activation-dependent membrane anchor, adding a lipid-interface component to the binding mechanism.\",\n      \"evidence\": \"Molecular dynamics simulations validated by site-directed fluorescence spectroscopy on arrestin-1 with rhodopsin in membrane\",\n      \"pmids\": [\"28220785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane-anchor contribution to overall binding energetics not quantified\", \"Single-lab combination of simulation and spectroscopy\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Pinpointed the finger loop as the activation sensor that specifically reads the active receptor conformation, separating activation detection from phosphate sensing.\",\n      \"evidence\": \"Comprehensive alanine-scanning of finger-loop residues with cell-free translated mutants and in vitro binding to defined rhodopsin forms\",\n      \"pmids\": [\"33159335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural arrangement of the engaged finger loop in the complex not directly visualized\", \"Cooperativity with C-edge and phosphate sensing not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed that inositol phosphates prime arrestin by displacing its C-tail at the N-domain basic patch without disrupting the polar core, distinguishing priming from full activation.\",\n      \"evidence\": \"X-ray crystallography of bovine arrestin-1 in ligand-free and InsP-bound states\",\n      \"pmids\": [\"34678158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of InsP priming in vivo not established\", \"How priming accelerates subsequent rhodopsin engagement not kinetically defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the priming, phosphate-sensing, finger-loop activation, and membrane-anchoring steps are temporally ordered into a single high-affinity complex in the native rod remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No integrated kinetic model coupling InsP priming to receptor engagement\", \"In vivo relevance of individual binding elements not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RHO\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}